Therefore, in this study, we performed a pooled immunophenotyping including stem/progenitor antigens (CD38/CD19/CD117), mature myeloid antigens (CD15/CD11b) and lymphoid antigens (CD4/CD56/CD7) in CD34+ blasts of MDS. This evidence concerns the gene CD19 and myelodysplastic syndrome.